Danielle Burkhalter - 13 Mar 2026 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Mar 2026, 16:07:42 UTC
Prior SEC filing
09 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jennifer Baldock, Attorney-in-Fact

Key filing fact

Danielle Burkhalter filed Form 4 for Surgery Partners, Inc. (SGRY) on 16 Mar 2026.

Key facts

  • This page summarizes Danielle Burkhalter's Form 4 filing for Surgery Partners, Inc. (SGRY).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Mar 2026, 16:07.

Change

  • Previous filing in this sequence was filed on 09 Mar 2026.
  • Current net transaction value: -$44,507.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001966798 Primary reporting owner

Burkhalter Danielle

Relationship
Chief Human Resources Officer
Address
C/O SURGERY PARTNERS, INC., 340 SEVEN SPRINGS WAY SUITE 600, BRENTWOOD
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Signature date
16 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGRY transaction

Common Stock

Sale

Transaction value
$44,507
Shares
-3,469
Change %
-4.3%
Price
$12.83
Shares after
76,864
Date
13 Mar 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .